Similar articles

• Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).

  Lum CT, Sutherland DE, Najarian JS. Lum CT, et al. Clin Immunol Immunopathol. 1979 Apr;12(4):453-9. doi: 10.1016/0090-1229(79)90050-3. Clin Immunol Immunopathol. 1979. PMID: 222523 No abstract available.
• Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase.

  Plunkett W, Alexander L, Chubb S, Loo TL. Plunkett W, et al. Cancer Res. 1979 Sep;39(9):3655-60. Cancer Res. 1979. PMID: 476690 No abstract available.
• Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.

  Shewach DS, Plunkett W. Shewach DS, et al. Biochem Pharmacol. 1982 Jun 1;31(11):2103-9. doi: 10.1016/0006-2952(82)90427-0. Biochem Pharmacol. 1982. PMID: 6180754 No abstract available.
• In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.

  Agarwal RP. Agarwal RP. Biochem Pharmacol. 1980 Feb;29(2):187-93. doi: 10.1016/0006-2952(80)90327-5. Biochem Pharmacol. 1980. PMID: 6965857 No abstract available.
• Inhibitors of adenosine deaminase.

  Agarwal RP. Agarwal RP. Pharmacol Ther. 1982;17(3):399-429. doi: 10.1016/0163-7258(82)90023-7. Pharmacol Ther. 1982. PMID: 6187032 Review. No abstract available.